MJ
Elite in Cholangiocarcinoma (Bile Duct Cancer)
Check Dr. Milind M. Javle's experience treating your condition:
About Dr. Milind M. Javle

Milind Javle is an Oncologist and a Hematologist Oncology expert in Houston, Texas. Javle has been practicing medicine for over 33 years and is rated as an Elite expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 12 other conditions, according to our data. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Pancreatic Cancer, Gallbladder Removal, and Hormone Replacement Therapy (HRT). He is licensed to treat patients in Texas and New York. Javle is currently accepting new patients.

His clinical research consists of co-authoring 189 peer reviewed articles and participating in 17 clinical trials in the past 15 years. In particular, he has co-authored 68 articles and participated in 11 clinical trials in the study of Cholangiocarcinoma (Bile Duct Cancer).

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Milind M. Javle it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
1515 Holcombe Blvd, 30 Unit Number 4, Houston, TX 77030
Background & Education
Graduate Institution
Other, 1990
Specialties
Oncology
Hematology Oncology
Licenses
Internal Medicine in NY
Hospital Affiliations
University Of Texas MD Anderson Cancer Center
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


17 Clinical Trials

A Phase II Study of Olaparib in Patients With Advanced Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations
A Phase II, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of TT-00420 Tablet in Adult Patients With Advanced Cholangiocarcinoma
A Phase 1b/2 Pressure Enabled Regional Immuno-Oncology Study of Hepatic Arterial Infusion of SD-101 With Systemic Checkpoint Blockade for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers
A Single-Arm Feasibility Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk Intrahepatic Cholangiocarcinoma
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
A Phase II Study of Ramucirumab for Advanced, Pre-Treated Biliary Cancers
A Phase II Study of Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers
ZD1839 (IRESSA®) With Oxaliplatin and Radiotherapy for Esophageal Carcinoma. A Phase I/II Study With Biologic Correlates
A Phase II Study of Gemcitabine in Combination With Capecitabine in Advanced Cholangiocarcinoma
Olaparib for BRCAness Phenotype in Pancreatic Cancer: Phase II Study
Phase II Study of Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer
View 12 Less Clinical Trials -

189 Total Publications

Gallbladder cancer.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Distinguished
Distinguished